{"id":"https://openalex.org/W2982811533","doi":"https://doi.org/10.1182/blood-2019-128570","title":"Lack of Significant Differences in Somatic Alterations between MGUS, SMM and Symptomatic Multiple Myeloma: A Result from Comprehensive Genomic Profiling Study","display_name":"Lack of Significant Differences in Somatic Alterations between MGUS, SMM and Symptomatic Multiple Myeloma: A Result from Comprehensive Genomic Profiling Study","publication_year":2019,"publication_date":"2019-11-13","ids":{"openalex":"https://openalex.org/W2982811533","doi":"https://doi.org/10.1182/blood-2019-128570","mag":"2982811533"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2019-128570","doi":"https://doi.org/10.1182/blood-2019-128570","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-128570","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067318207","display_name":"An\u0131l Akta\u015f Samur","orcid":"https://orcid.org/0000-0002-0183-0562","observed_orcids":["https://orcid.org/0000-0002-0183-0562"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anil Aktas Samur","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062468245","display_name":"Mariateresa Fulciniti","orcid":"https://orcid.org/0000-0002-1432-9742","observed_orcids":["https://orcid.org/0000-0002-1432-9742"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mariateresa Fulciniti","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055748047","display_name":"Raphael Elie Szalat","orcid":"https://orcid.org/0000-0002-6198-3405","observed_orcids":["https://orcid.org/0000-0002-6198-3405"]},"institutions":[{"id":"https://openalex.org/I111088046","display_name":"Boston University","ror":"https://ror.org/05qwgg493","country_code":"US","type":"education","lineage":["https://openalex.org/I111088046"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raphael Szalat","raw_affiliation_strings":["Boston University School of Medicine, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Boston University School of Medicine, Boston, MA","institution_ids":["https://openalex.org/I111088046"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030565933","display_name":"Jill Corre","orcid":"https://orcid.org/0000-0003-1580-6106","observed_orcids":["https://orcid.org/0000-0003-1580-6106"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jill Corre","raw_affiliation_strings":["Unite de Genomique du Myelome, IUC-T Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unite de Genomique du Myelome, IUC-T Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051626849","display_name":"Niccol\u00f2 Bolli","orcid":"https://orcid.org/0000-0002-1018-5139","observed_orcids":["https://orcid.org/0000-0002-1018-5139"]},"institutions":[{"id":"https://openalex.org/I189158943","display_name":"University of Milan","ror":"https://ror.org/00wjc7c48","country_code":"IT","type":"education","lineage":["https://openalex.org/I189158943"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Niccolo Bolli","raw_affiliation_strings":["Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology and Onco-Hematology, University of Milan, Milan, Italy","institution_ids":["https://openalex.org/I189158943"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103143602","display_name":"Philippe Moreau","orcid":"https://orcid.org/0000-0003-1780-8746","observed_orcids":["https://orcid.org/0000-0003-1780-8746"]},"institutions":[{"id":"https://openalex.org/I3019204325","display_name":"Centre Hospitalier Universitaire de Nantes","ror":"https://ror.org/05c1qsg97","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019204325"]},{"id":"https://openalex.org/I97188460","display_name":"Nantes Universit\u00e9","ror":"https://ror.org/03gnr7b55","country_code":"FR","type":"education","lineage":["https://openalex.org/I97188460"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Moreau","raw_affiliation_strings":["Clinical Hematology, University Hospital H\u00f4tel-Dieu, Nantes, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Hematology, University Hospital H\u00f4tel-Dieu, Nantes, France","institution_ids":["https://openalex.org/I3019204325","https://openalex.org/I97188460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025996929","display_name":"Michel Attal","orcid":"https://orcid.org/0000-0002-0136-9665","observed_orcids":["https://orcid.org/0000-0002-0136-9665"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Michel Attal","raw_affiliation_strings":["Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050977500","display_name":"Giovanni Parmigiani","orcid":"https://orcid.org/0000-0002-8783-5961","observed_orcids":["https://orcid.org/0000-0002-8783-5961","https://orcid.org/0000-0002-4791-3072"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Giovanni Parmigiani","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063422967","display_name":"Herv\u00e9 Avet\u2010Loiseau","orcid":"https://orcid.org/0000-0002-3050-0140","observed_orcids":["https://orcid.org/0000-0002-3050-0140"]},"institutions":[{"id":"https://openalex.org/I4210098740","display_name":"Institut universitaire du cancer de Toulouse Oncopole","ror":"https://ror.org/014hxhm89","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017","https://openalex.org/I4210098740","https://openalex.org/I4210128666"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Herv\u00e9 Avet-Loiseau","raw_affiliation_strings":["Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France","institution_ids":["https://openalex.org/I4210098740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041668980","display_name":"Mehmet Samur","orcid":"https://orcid.org/0000-0002-9978-5682","observed_orcids":["https://orcid.org/0000-0002-9978-5682"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]},{"id":"https://openalex.org/I4210134579","display_name":"Dana-Farber/Harvard Cancer Center","ror":"https://ror.org/03pvyf116","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehmet Kemal Samur","raw_affiliation_strings":["The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453","https://openalex.org/I4210134579"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"134","issue":"Supplement_1","first_page":"3089","last_page":"3089"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.8759999871253967},{"id":"https://openalex.org/keywords/monoclonal-gammopathy-of-undetermined-significance","display_name":"monoclonal gammopathy of undetermined significance","score":0.949999988079071},{"id":"https://openalex.org/keywords/smoldering-multiple-myeloma","display_name":"smoldering multiple myeloma","score":0.9850000143051147},{"id":"https://openalex.org/keywords/somatic-alterations","display_name":"somatic alterations","score":0.8519999980926514},{"id":"https://openalex.org/keywords/single-nucleotide-variants","display_name":"single nucleotide variants","score":0.9020000100135803},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.9710000157356262},{"id":"https://openalex.org/keywords/structural-variants","display_name":"structural variants","score":0.9959999918937683},{"id":"https://openalex.org/keywords/clonality","display_name":"clonality","score":0.7070000171661377},{"id":"https://openalex.org/keywords/mutational-load","display_name":"mutational load","score":0.7900000214576721},{"id":"https://openalex.org/keywords/multiple-myeloma-progression","display_name":"progression to multiple myeloma","score":0.7580000162124634},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.5120000243186951},{"id":"https://openalex.org/keywords/plasma-cell-dyscrasia","display_name":"plasma cell dyscrasia","score":0.4000000059604645}],"concepts":[{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7260128259658813},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5483423471450806},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.49894237518310547},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4470076262950897},{"id":"https://openalex.org/C134305767","wikidata":"https://www.wikidata.org/wiki/Q725508","display_name":"Somatic cell","level":3,"score":0.4265348017215729},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.42572855949401855},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.412285178899765},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37845706939697266},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2572237253189087},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.11738130450248718},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2019-128570","doi":"https://doi.org/10.1182/blood-2019-128570","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2019-128570","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2726987301","https://openalex.org/W3092899955","https://openalex.org/W2953195693","https://openalex.org/W2260827900","https://openalex.org/W4310099707","https://openalex.org/W2983172312","https://openalex.org/W4389234553","https://openalex.org/W3097881743","https://openalex.org/W1983235956","https://openalex.org/W2905292067"],"abstract_inverted_index":{"Somatic":[0],"alterations":[1,9,28],"including":[2,398],"single":[3],"nucleotide":[4],"variants":[5,13],"(SNVs),":[6],"copy":[7,369],"number":[8,268,370],"(CNAs)":[10],"and":[11,19,51,65,75,90,101,129,138,149,172,181,208,250,294,304,339,361,386,401,407,428,469,481,502,509],"structural":[12],"(SVs)":[14],"are":[15],"an":[16],"important":[17],"component":[18],"the":[20,33,49,146,209,245,343,381,443,462,514,527],"hallmark":[21],"of":[22,36,53,122,151,162,244,345,359,376,380,437,461,478,493,507],"Multiple":[23],"Myeloma":[24],"(MM)":[25],"with":[26,68,88,204,278,291,435],"certain":[27],"having":[29],"clinical":[30],"implications.":[31],"Recently,":[32],"chronological":[34],"order":[35],"such":[37,54],"events":[38,55,430,465],"was":[39,211,220,323,372,392,454],"explained":[40],"in":[41,56,133,159,253,321,374,394,410,417,448,456,467,496],"detailed":[42],"studies":[43],"however":[44],"previous":[45],"study":[46],"has":[47],"compared":[48,255,285,342],"frequency":[50,150,161,320,344,358,406,445],"clonality":[52,131,408],"early":[57,427],"stage":[58,100,174,198],"plasma":[59],"cell":[60,265],"disorder":[61],"(MGUS":[62],"or":[63,520],"SMM)":[64],"their":[66,130],"comparison":[67],"MM.Here":[69],"we":[70,126,341,354],"performed":[71],"whole":[72],"genome":[73],"(WGS)":[74],"RNA":[76],"sequencing":[77],"(RNAseq)":[78],"on":[79,270],"67":[80],"samples":[81,85,97,246,272,484],"(8":[82],"Unique":[83],"paired":[84,96,271,479],"from":[86,196,288,331,475],"patients":[87,112,143,300,333,377],"MGUS":[89,165],"when":[91],"progressed":[92,103,116],"to":[93,104,144,184,199,256,311,325,352,414,525],"MM,":[94,105,353],"10":[95],"at":[98,118,164,182,229,234,239,334,347,442],"SMM":[99,110,137,173,290,293,299,338,363,411,424],"then":[102],"as":[106,108,419,421,447,485,487],"well":[107,420,486],"non-progressor":[109,289,298],"(NP-SMM)":[111],"who":[113],"have":[114,284],"not":[115,155,212,305],"after":[117],"least":[119],"5":[120],"years":[121],"follow-up.":[123],"In":[124,241,365,471],"addition,":[125],"profiled":[127],"CNAs":[128,303,346],"level":[132,446],"164":[134],"MGUS,":[135,230],"147":[136],"336":[139],"newly":[140],"diagnosed":[141],"MM":[142,185,200,254,418,483],"construct":[145],"clonal":[147,368,429],"structure":[148],"somatic":[152],"alterations.We":[153],"did":[154],"observe":[156],"significant":[157,214,452,494],"difference":[158,210,453],"overall":[160],"mutations":[163],"(median=5662":[166],"SNVs,":[167,176,188],"IQR=":[168,226,232,237],"[5252":[169],"-":[170,178,190],"7864])":[171],"(median=5308":[175],"IQR=[4236":[177],"6125]":[179],")":[180],"progression":[183],"(median=":[186],"5983":[187],"IQR=[5097":[189],"8916]).":[191],"Overall":[192],"mutational":[193],"load":[194,252],"increased":[195,263],"precursor":[197,257,480,500],"by":[201,328],"only":[202,277,451],"5%":[203],"no":[205],"recurrent":[206],"change":[207,512],"statistically":[213],"(p":[215],">":[216],"0.05).":[217],"Similar":[218,351],"trend":[219],"also":[221,273],"observed":[222,355,373,393,404,416,455,466],"for":[223,316,516],"SVs":[224],"[median=36,":[225],"[25.25":[227],"-40.75]":[228],"median=34,":[231],"[12-52]":[233],"SMM,":[235,367],"median=27,":[236],"[27-41]":[238],"MM].":[240],"fact,":[242],"some":[243,460],"had":[247,262,426],"lower":[248],"SNV":[249],"SV":[251],"stages":[258,336],"even":[259],"though":[260],"that":[261],"cancer":[264],"fraction.":[266],"Copy":[267],"analysis":[269,477],"showed":[274,301],">90%":[275],"similarity":[276],"few":[279],"non-recurrent":[280],"focal":[281],"CNAs.":[282],"We":[283],"WGS":[286],"data":[287,330,474,490],"progressor":[292],"newly-diagnosed":[295],"MM.":[296,449],"The":[297,403,450],"identical":[302,413],"significantly":[306],"different":[307],"Ig":[308],"translocation":[309],"frequencies":[310],"both":[312],"other":[313,395],"groups.":[314],"Except":[315],"NRAS":[317],"mutations,":[318],"mutation":[319],"NP-SMM":[322],"similar":[324,390],"others.":[326],"Finally,":[327],"using":[329],"647":[332],"three":[335,382],"(MGUS,":[337],"MM),":[340],"each":[348],"time":[349],"point.":[350],"almost":[356],"equal":[357],"hyperdiploid":[360,366,396],"non-hyperdiploid":[362],"cases.":[364],"gain":[371,436],"95%":[375],"involving":[378],"two":[379],"chromosomes":[383,397,399],"9,":[384],"15":[385],"19.":[387],"Moreover,":[388],"a":[389],"pattern":[391],"3,5,7,11":[400],"21.":[402],"event":[405],"levels":[409],"were":[412],"one":[415],"MGUS.":[422],"Non-hyperdiploid":[423],"group":[425],"targeting":[431,459],"chromosome":[432],"13":[433],"deletion":[434,464],"1q,":[438],"11":[439],"and/or":[440],"9":[441],"same":[444],"subclonal":[457],"deletions":[458],"infrequent":[463],"HMM":[468],"NHMM.":[470],"conclusion,":[472],"our":[473],"longitudinal":[476],"symptomatic":[482,503],"cross":[488],"sectional":[489],"highlight":[491],"lack":[492,506],"differences":[495],"genomic":[497,511],"changes":[498,524],"between":[499],"conditions":[501],"myeloma.":[504],"This":[505],"progressive":[508],"unique":[510],"suggests":[513],"need":[515],"additional":[517],"transcriptomic,":[518],"epigenomic":[519],"tumor":[521,528],"micro":[522],"environment":[523],"accelerate":[526],"development.":[529],"Disclosures":[530],"Bolli:":[531],"Celgene:":[532,549,576],"Honoraria;":[533,542,545,548,551],"Gilead:":[534],"Other:":[535,556,561,565],"travel":[536],"expenses;":[537],"Novartis:":[538],"Honoraria.":[539,554],"Moreau:Amgen:":[540],"Consultancy,":[541,544,547,550,553,569,573,577,581],"Takeda:":[543,572,590],"AbbVie:":[546],"Janssen:":[552,568,588],"Anderson:Sanofi-Aventis:":[555],"Advisory":[557],"Board;":[558],"Bristol-Myers":[559],"Squibb:":[560],"Scientific":[562,566],"Founder;":[563,567],"Oncopep:":[564,586],"Speakers":[570,574,578,582],"Bureau;":[571,575,579],"Amgen:":[580,592],"Bureau.":[583],"Munshi:Celgene:":[584],"Consultancy;":[585,587,589,591,593,595],"Adaptive:":[594],"Abbvie:":[596],"Consultancy.":[597]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2019-11-22T00:00:00"}